The rare patients who are able to spontaneously control HIV replication in the absence of therapy show signs of a particularly efficient cellular immune response. To identify the molecular determinants that underlie this response, we characterized the T cell receptor (TCR) repertoire directed at Gag293, the most immunoprevalent CD4 epitope in the HIV-1 capsid. HIV controllers from the ANRS CODEX cohort showed a highly skewed TCR repertoire that was characterized by a predominance of
Daniela Benati, Moran Galperin, Olivier Lambotte, Stéphanie Gras, Annick Lim, Madhura Mukhopadhyay, Alexandre Nouël, Kristy-Anne Campbell, Brigitte Lemercier, Mathieu Claireaux, Samia Hendou, Pierre Lechat, Pierre de Truchis, Faroudy Boufassa, Jamie Rossjohn, Jean-François Delfraissy, Fernando Arenzana-Seisdedos, Lisa A. Chakrabarti
Title and authors | Publication | Year |
---|---|---|
Enhanced Cross-Reactive and Polyfunctional Effector-Memory T Cell Responses by ICVAX—a Human PD1-Based Bivalent HIV-1 Gag-p41 Mosaic DNA Vaccine
S Chen, Y Wong, L Yim, H Zhang, H Wang, G Lui, X Li, X Tang, L Cheng, Y Du, Q Peng, J Wang, H Kwok, H Huang, T Lau, D Chan, B Wong, L Liu, L Chakrabarti, S Lee, Z Chen, G Silvestri |
Journal of virology | 2022 |
Low CCR5 expression protects HIV-specific CD4+ T cells of elite controllers from viral entry
M Claireaux, R Robinot, J Kervevan, M Patgaonkar, I Staropoli, A Brelot, A Nouël, S Gellenoncourt, X Tang, M Héry, S Volant, E Perthame, V Avettand-Fenoël, J Buchrieser, T Cokelaer, C Bouchier, L Ma, F Boufassa, S Hendou, V Libri, M Hasan, D Zucman, P de Truchis, O Schwartz, O Lambotte, L Chakrabarti |
Nature Communications | 2022 |
A nano-enhanced vaccine for metastatic melanoma immunotherapy
Salotto KE, Olson Jr WC, Pollack KE, Illendula A, Michel E, Henriques S, Fox T, Walker S, Dunlap-Brown M, Slingluff Jr CL, Kester M, Snyder HW |
2022 | |
HIV-1-infected CD4+ T cells present MHCII-restricted epitope via endogenous processing
Addison MM, Ellis GI, Leslie GJ, Zawadzky NB, Riley JL, Hoxie JA, Eisenlohr LC |
Journal of immunology (Baltimore, Md. : 1950) | 2022 |
Perturbations in the T cell receptor β repertoire during malaria infection in children: A preliminary study.
Frimpong A, Ofori MF, Degoot AM, Kusi KA, Gershom B, Quartey J, Kyei-Baafour E, Nguyen N, Ndifon W |
Frontiers in immunology | 2022 |
Safety and durability of AGT103-T autologous T cell therapy for HIV infection in a Phase 1 trial
Muvarak N, Li H, Lahusen T, Galvin JA, Kumar PN, Pauza CD, Bordon J |
Frontiers in Medicine | 2022 |
Dysfunctional Sars-CoV-2-M protein-specific cytotoxic T lymphocytes in patients recovering from severe COVID-19
Ogura H, Gohda J, Lu X, Yamamoto M, Takesue Y, Son A, Doi S, Matsushita K, Isobe F, Fukuda Y, Huang TP, Ueno T, Mambo N, Murakami H, Kawaguchi Y, Inoue JI, Shirai K, Yamasaki S, Hirata JI, Ishido S |
Nature Communications | 2022 |
Elite and posttreatment controllers, two facets of HIV control.
Mastrangelo A, Banga R, Perreau M |
Current Opinion in HIV and AIDS | 2022 |